The second season of the Infectious Science podcast is being recorded in the Galveston National Lab, with Dr. Dennis Bente leading the effort and including students who are loving the creative outlet.

The University of Texas Medical Branch recently received a three-year award of $15.6 million per year from NIAID to conduct cutting-edge research aimed at developing vaccines and monoclonal antibodies (mAbs) to combat high-priority viral pathogens.

In August, five recent medical school graduates who are participating in the UTMB Aerospace Medicine Residency Program spent an afternoon at the GNL learning about research in different kinds of “extreme environments.”

The Galveston National Lab is the proud sponsor of Infectious Science, a podcast produced by a team of faculty, staff and students interested in sharing their love of science. The podcast covers a wide range of topics, weaving in interesting, often little known stories about emerging pathogens or historical outbreaks.

A recent study at the University of Texas Medical Branch, published in Nature Communications, has shown that an mRNA vaccine developed by UTMB scientists protects against Andes virus in an animal model. Andes virus is a prominent rodent-borne virus in South America and has human fatality rates up to 30 percent.

The Galveston National Laboratory (GNL) experienced its second named storm of the season on July 8, and despite Category 1 hurricane winds and driving rains from Hurricane Beryl, the facility performed as designed and was unscathed by the assault.

Personnel from the GNL hosted representatives from Brazil's Ministry of Defense to share best practices in laboratory design, operation and safety. Brazil is in the planning phase for new high containment labs to manage emerging infectious disease research.

In this episode, listeners will come away with a wealth of knowledge about bird flu strains, how they spread, the risk to migratory bird populations, commercial flocks, backyard chickens and mammals.

In a paper published in the journal Proceedings of the National Academy of Sciences, UTMB’s scientists document how a new drug from Zalgen Labs successfully cured cynomolgus monkeys infected with Lassa virus.

A new president has taken over at the University of Texas Medical Branch. This interview appeared in the Galveston County Daily News.

The first clinical trial testing two drugs to treat Crimean Congo Hemorrhagic Fever is underway in Turkey, and UTMB’s Dr. Gary Kobinger is one of the forces behind this successful project.

Six undergraduate students from Asia University in Taiwan who are studying healthcare administration received an introduction to healthcare systems in America during a day at UTMB on Monday, July 17.

The Galveston National Lab hosted an impressive group of visitors on Friday, June 2.

Dr. Tom Geisbert and Dr. Robert Cross are co-PIs on a new project agreement awarded by the US Department of Defense and BARDA for vaccine development targeting pathogens of concern to U.S. Military.